Snellgrove Darren bought HALO
July 1, 2026 · Form 4 insider transaction
Snellgrove Darren bought 127,432 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
127,432
Price
$0.00
Total value
N/A
InsiderSnellgrove Darren
Role—
SecurityOption to Purchase Common Stock
Transaction codeA: Grant or award
Transaction dateJuly 1, 2026
Filing dateJuly 2, 2026
Shares owned after127,432
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option vests one-fourth on such date and then 1/48th monthly thereafter.